by Insception Lifebank | Blog, blood cancer, cord blood application, FDA, Health and Wellness, Research
The FDA made history in April with its first-ever approval of an expanded cord blood product for use as a primary treatment in hematopoietic stem cell transplants (HSCT) for certain blood cancers in adults and children 12 years of age and older.1 Why is cord blood...
by Insception Lifebank | Blog, blood cancer, cord blood application, FDA, Health and Wellness, Research
Share this article : “Wait! Wait! Wait! I have something for you.” What that nurse at the ultrasound center had for expecting mom Jessica Fox was a CBR®, our American sister company’s brochure. Just weeks after learning she was pregnant with their first child,...
by Muhammad Faisal | Blog, Cord Blood, Cord blood stem cells, Research, Science & Research, Stem Cell Research
Share this article : An American research team has announced that for the first time a woman appears to have been cured of HIV following a transplant of umbilical cord blood stem cells.1 The “New York patient,” as the woman is referred to by researchers, is now the...
by Insception Lifebank | Blog, Clinical Trials, Multiple Sclerosis, Research
In recent years, the list of diseases and conditions being studied in clinical trials has grown exponentially. While, 10 years ago, the announcement of a stem cell clinical trial for a condition other than cancer would have been revolutionary, this year alone, Ontario...
by Insception Lifebank | Autism, Blog, Clinical Trials, Cord Blood, Research
Dr. Joanne Kurtzberg, at Duke University in North Carolina, is a leader in the cord blood field for both transplantation and regenerative medicine. Currently, she’s investigating the effectiveness of cord blood in a variety of paediatric conditions associated with...
Sign in 
